Genetic biomarker IDs patients with increased risk for heart damage by anthracycline chemo
Monday, December 19, 2016 - 12:01
in Health & Medicine
Among women with breast cancer who received a type of chemotherapy called an anthracycline, those who had a certain genetic biomarker had a significantly increased risk for having anthracycline-induced congestive heart failure.